Adverse hemodynamic effects of a selective endothelin ETB receptor antagonist in patients with chronic heart failure:: reversal with a selective endothelin ETA receptor antagonist

被引：0
|
作者：
Cowburn, PJ
Cleland, JGF
McDonagh, TA
McArthur, JD
MacLean, MR
Dargie, HJ
机构：
[1] Univ Glasgow, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland
来源：
CIRCULATION | 1998年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3773
引用
收藏
页码：718 / 718
页数：1
相关论文
共 50 条
  • [41] Comparison of therapeutic benefit with an endothelin-A receptor and a mixed endothelin receptor antagonist in heart failure
    Ohnishi, M
    Wada, A
    Tsutamoto, T
    Maeda, Y
    Fukai, D
    Maeda, K
    Hisanaga, T
    CIRCULATION, 1996, 94 (08) : 1545 - 1545
  • [42] Dual ETA/ETB vs. selective ETA endothelin receptor antagonism in patients with pulmonary hypertension
    Opitz, C. F.
    Ewert, R.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 1 - 9
  • [43] Hemodynamic effects of a selective endothelin-A receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats
    Yu, M
    Gopalakrishnan, V
    McNeill, JR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S262 - S264
  • [44] Practical asymmetric synthesis of an endothelin A receptor selective antagonist.
    Song, ZJ
    Zhao, M
    Frey, LF
    Zhao, DL
    Tan, LS
    Li, J
    Chen, CY
    Tschaen, DM
    Tillyer, RD
    Grabowski, EJJ
    Volante, R
    Reider, PJ
    Okada, S
    Sato, H
    Nemoto, T
    Kato, Y
    Akao, A
    Hiraga, S
    Tsuchiya, Y
    Tomimoto, K
    Mase, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U80 - U80
  • [45] PD-156707: A selective endothelin-A receptor antagonist
    Uprichard, ACG
    Metz, AL
    Hallak, H
    Haleen, SJ
    CARDIOVASCULAR DRUG REVIEWS, 1998, 16 (02): : 89 - 104
  • [46] Effect of YM598, a selective endothelin ETA receptor antagonist, on endothelin-1-induced bone formation
    Someya, Akiyoshi
    Yuyama, Hironori
    Fujimori, Akira
    Ukai, Masashi
    Fukushima, Shinji
    Sasamata, Masao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 543 (1-3) : 14 - 20
  • [47] BQ-123, A SELECTIVE ENDOTHELIN ET(A) RECEPTOR ANTAGONIST
    MORELAND, S
    CARDIOVASCULAR DRUG REVIEWS, 1994, 12 (01): : 48 - 69
  • [48] Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist for the treatment of pulmonary arterial hypertension
    Kingman, Martha
    Ruggiero, Rosechelle
    Torres, Fernando
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (11) : 1847 - 1858
  • [49] In vitro and in vivo effects of endothelin-1 and YM598, a selective endothelin ETA receptor antagonist, on the lower urinary tract
    Ukai, Masashi
    Yuyama, Hironori
    Fujimori, Akira
    Koakutsu, Akiko
    Sanagi, Masanao
    Itake, Akiyoshi
    Sato, Shuichi
    Sudoh, Katsumi
    Sasamata, Masao
    Miyata, Keiji
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 580 (03) : 394 - 400
  • [50] The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure
    Schalcher, C
    Cotter, G
    Reisin, L
    Bertel, O
    Kobrin, I
    Guyene, TT
    Kiowski, W
    AMERICAN HEART JOURNAL, 2001, 142 (02) : 340 - 349
12345